Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Inventories, Finished Goods: ¥337 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603392 Beijing Wantai Biological Pharmacy Enterprise Co Ltd SHSE:603392
54 GF Score
Price ¥30.70
GF Value ¥49.59
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Beijing Wantai Biological Pharmacy Enterprise Co Inventories, Finished Goods?

Beijing Wantai Biological Pharmacy Enterprise Co SHSE:603392 -0.68% 54 Inventories, Finished Goods is ¥337 Mil as of Jun. 2026. GuruFocus rates SHSE:603392 with a GF Score™ of 54/100 and a GF Value™ of ¥49.59 (Possible Value Trap). The stock has 2 warning signs investors should review.

Beijing Wantai Biological Pharmacy Enterprise Co's quarterly finished goods declined from Dec. 2025 (¥288 Mil) to Mar. 2026 (¥0 Mil) but then increased from Mar. 2026 (¥0 Mil) to Jun. 2026 (¥337 Mil).

Beijing Wantai Biological Pharmacy Enterprise Co's annual finished goods declined from Dec. 2023 (¥422 Mil) to Dec. 2024 (¥371 Mil) and declined from Dec. 2024 (¥371 Mil) to Dec. 2025 (¥288 Mil).

Beijing Wantai Biological Pharmacy Enterprise Co Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Beijing Wantai Biological Pharmacy Enterprise Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Wantai Biological Pharmacy Enterprise Co Inventories, Finished Goods Chart

Beijing Wantai Biological Pharmacy Enterprise Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 191.04 301.18 422.02 371.49 287.88

Beijing Wantai Biological Pharmacy Enterprise Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 464.50 0.00 287.88 0.00 337.02
SHSE:603392
54GF Score
Beijing Wantai Biological Pharmacy Enterprise Co Ltd SHSE:603392
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Wantai Biological Pharmacy Enterprise Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ¥337 Mil mean?
Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) has a Inventories, Finished Goods of ¥337 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Beijing Wantai Biological Pharmacy Enterprise Co and its competitors.
Is Beijing Wantai Biological Pharmacy Enterprise Co's Inventories, Finished Goods too high?
Beijing Wantai Biological Pharmacy Enterprise Co's current Inventories, Finished Goods is ¥337 Mil. Overall, Beijing Wantai Biological Pharmacy Enterprise Co has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beijing Wantai Biological Pharmacy Enterprise Co's Inventories, Finished Goods compare to VRTX and REGN?
Beijing Wantai Biological Pharmacy Enterprise Co's Inventories, Finished Goods of ¥337 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Beijing Wantai Biological Pharmacy Enterprise Co and its competitors. Beijing Wantai Biological Pharmacy Enterprise Co's current Inventories, Finished Goods is ¥337 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Wantai Biological Pharmacy Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) is currently considered Possible Value Trap. The stock's GF Value™ is ¥49.59, compared to a current price of ¥30.70 — trading 38.1% below its estimated fair value. The current Inventories, Finished Goods is ¥337 Mil. Beijing Wantai Biological Pharmacy Enterprise Co's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392), the current Inventories, Finished Goods is ¥337 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Wantai Biological Pharmacy Enterprise Co stock appears to be undervalued. The current stock price of ¥30.70 is trading 38.1% below its estimated GF Value™ of ¥49.59. GuruFocus considers Beijing Wantai Biological Pharmacy Enterprise Co to be Possible Value Trap.

Key valuation signals for SHSE:603392:

  • Inventories, Finished Goods: ¥337 Mil
  • GF Value™: ¥49.59 vs. price of ¥30.70 (38.1% below fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the SHSE:603392 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Wantai Biological Pharmacy Enterprise Co Business Description

Address No. 31, Science Park Road, Changping District, Beijing, CHN, 102206
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in research, development, production, and sales of in vitro diagnostic reagents, instruments, and vaccines. The company has two segments: Diagnostic and Vaccine. The Diagnostic segment develops and sells in vitro diagnostic reagents such as ELISA, colloidal gold, biochemical, and chemiluminescent kits, along with instruments including chemiluminescent analyzers, fluorescent analyzers, and nucleic acid purification systems. The Vaccine segment focuses on products like the hepatitis E vaccine, the bivalent HPV vaccine, and the nasal spray COVID-19 vaccine. It generates the majority of its revenue from the Diagnostic segment.
54GF Score

Get the complete analysis for SHSE:603392

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥30.70
Price
¥49.59
GF Value